Biphenyl amide p38 kinase inhibitors 2: Optimisation and SAR.
Richard M Angell, Tony D Angell, Paul Bamborough, David Brown, Murray Brown, Jacky B Buckton, Stuart G Cockerill, Chris D Edwards, Katherine L Jones, Tim Longstaff, Penny A Smee, Kathryn J Smith, Don O Somers, Ann L Walker, Malcolm Willson
文献索引:Bioorg. Med. Chem. Lett. 18(1) , 324-8, (2008)
全文:HTML全文
摘要
The biphenyl amides are a novel series of p38 MAP kinase inhibitors. Structure-activity relationships of the series against p38alpha are discussed with reference to the X-ray crystal structure of an example. The series was optimised rapidly to a compound showing oral activity in an in vivo disease model.
相关化合物
相关文献:
2009-01-01
[Bioorg. Med. Chem. Lett. 19(19) , 5632-5, (2009)]
2016-03-01
[J. Fluoresc. 26 , 609-15, (2016)]
Synthesis of a 2-benzazepine analog of a potent, nonpeptide GPIIb/IIIa antagonist. Miller WH, et al.
[Tetrahedron Lett. 36(3) , 373-76, (1995)]